On Mar. 26, 2025, UTA LEG reported bill approval by governor, effective May 7, 2025.
On Mar. 7, UTA LEG passed bill on medication in residential programs.
UTA LEG passed bill SB 65, amending UTA LEG 26B-2-101 and UTA LEG 26B-2-117, regarding the use of medication assisted treatment in residential treatment programs.
Require office of licensing establish, enforce rules on treatment use, technical changes.
Bill Provisions
Requires the Office of Licensing within the Department of Health and Human Services to establish and enforce rules concerning the use of medication assisted treatment.
Use of treatment in certain residential treatment programs and recovery residences.
Medication assisted treatment means use of a prescribed medication approved by FDA such as buprenorphine, methadone, or naltrexone, to treat substance use disorders.
Defines terms, including health insurer, makes various technical, conforming changes.
Legislative History
On Jan. 3, 2025, bill introduced in Senate; on Feb. 24, 2025, bill passed the Senate.
On Feb. 25, 2025, bill introduced in House; on Mar. 5, 2025, bill passed the House.
On Mar. 5, 2025, bill sent for enrolling; on Mar. 7, 2025, enrolled bill sent for printing.
Effectiveness
Upon governor approval, this bill will take effect on May 7, 2025.
Mar. 26, 2025 UTA LEG Bill Approval
On Mar. 26, 2025, UTA LEG reported bill approval by governor, effective May 7, 2025.
